3Barthel S R,Gavino J D, Descheny L, et al. Targetingselectins and selectin ligands in inflammation and cancer[J3. Expert Opinion on Therapeutic Targets, 2007, 11(11):1473-1491.
5Shao B,Yago T, Coghill P A, et al. Signal-dependentslow leukocyte rolling does not require cytoskeletal an-chorage of P-selectin glycoprotein ligand-1 (PSGL-1) orintegrin aLp2[J], Journal of Biological Chemistry, 2012,287(23):19585-19598.
6Grailer J J, Kodera M, Steeber D A. L-selectin:Role inregulating homeostasis and cutaneous inflammation[J].Journal of Dermatological Science,2009, 56(3):141-147.
7Buttari B,Profumo E? Di Cristofano C, et al. Haemoglo-bin triggers chemotaxis of human monocyte-derived den-dritic cells:Possible role in atherosclerotic lesion instabil-ity[J]# Atherosclerosis,2011, 215(2):316-322.
8Haagsman H P, Hogenkamp A,van Eijk M,et al. Sur-factant collectins and innate immunity [J], Neonatology,2008,93(4):288-294.
9Visser L G. TNF-a Antagonists and ImmunizationCJD?Current Infectious Disease Reports, 2011, 13 (3):243-247.
10O Reilly M K, Paulson J C. Siglecs as targets for thera-py in immune-cell-mediated disease[J]. Trends in phar-macological sciences,2009,30(5):240-248.
6Crocker PR, Paulson JC, Varki A. Siglees and their roles in the immune system [J]. Nat Rev Immunol, 2007,7 (4): 255-266.
7Varki A, Angata T. Siglees-the major subfamily of I-type leetins [J]. Glycobiology, 2006,16(1) : 1R-27R.
8Hoffmann A, Kerr S,Jellusova J, et al. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population [J]. Nat Immunol,2007,8(7) : 695-704.
9Angata T, Hayakawa T, Yamanaka M, et aI. Discovery of Siglec- 14, a novel sialie aeid receptor undergoing concerted evolution with Siglee-5 in primates [J]. FASEB J, 2006, 20 (12): 1964- 1973.
10Blasius AL, Colonna M. Sampling and signaling in plasmaeytoid dendritic cells: the potential roles of Siglec-H [J]. Trends Immunol,2006,27(6) : 255-260.
